Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-22-000958
Filing Date
2022-08-10
Accepted
2022-08-10 16:32:02
Documents
45
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mana_10q-063022.htm   iXBRL 10-Q 430210
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 7765
3 EXHIBIT 31.3 ex31x2.htm EX-31.2 7800
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 3482
5 EXHIBIT 32.2 ex32x2.htm EX-32.2 3615
  Complete submission text file 0001079973-22-000958.txt   2342667

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE maaq-20220630.xsd EX-101.SCH 24771
7 XBRL CALCULATION FILE maaq-20220630_cal.xml EX-101.CAL 26209
8 XBRL DEFINITION FILE maaq-20220630_def.xml EX-101.DEF 104115
9 XBRL LABEL FILE maaq-20220630_lab.xml EX-101.LAB 162294
10 XBRL PRESENTATION FILE maaq-20220630_pre.xml EX-101.PRE 148101
39 EXTRACTED XBRL INSTANCE DOCUMENT mana_10q-063022_htm.xml XML 235268
Mailing Address 8 THE GREEN SUITE 12490 DOVER DE 19901
Business Address 8 THE GREEN SUITE 12490 DOVER DE 19901 302-281-2147
Mana Capital Acquisition Corp. (Filer) CIK: 0001870144 (see all company filings)

EIN.: 870925574 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41097 | Film No.: 221152275
SIC: 2835 In Vitro & In Vivo Diagnostic Substances